Yousif Capital Management’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-11,272
Closed -$1.11M 1888
2025
Q2
$1.11M Sell
11,272
-278
-2% -$26.3K 0.01% 1078
2025
Q1
$1.07M Sell
11,550
-284
-2% -$26.2K 0.01% 1073
2024
Q4
$1.07M Sell
11,834
-569
-5% -$52.3K 0.01% 1108
2024
Q3
$1.2M Sell
12,403
-1,628
-12% -$159K 0.01% 1079
2024
Q2
$1.29M Sell
14,031
-1,030
-7% -$95.6K 0.01% 983
2024
Q1
$1.39M Sell
15,061
-342
-2% -$32K 0.02% 1018
2023
Q4
$1.46M Buy
15,403
+26
+0.2% +$2.43K 0.02% 999
2023
Q3
$1.44M Sell
15,377
-830
-5% -$76.7K 0.02% 931
2023
Q2
$1.48M Sell
16,207
-467
-3% -$38.3K 0.02% 942
2023
Q1
$1.23M Sell
16,674
-55
-0.3% -$4.76K 0.02% 1044
2022
Q4
$1.4M Buy
16,729
+73
+0.4% +$6.58K 0.02% 991
2022
Q3
$1.61M Sell
16,656
-1,662
-9% -$198K 0.02% 882
2022
Q2
$1.93M Buy
18,318
+1,010
+6% +$129K 0.03% 848
2022
Q1
$2.98M Buy
17,308
+335
+2% +$50K 0.03% 651
2021
Q4
$2.75M Buy
+16,973
New +$2.73M 0.03% 742

Other funds holding AMED

Yousif Capital Management's AMED Position: Q3 2025 in Review

Yousif Capital Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 11,272 shares — an estimated $1.11M sold.

Yousif Capital Management first reported a position in AMED in Q4 2021 and held it in 15 quarters. The position peaked at $2.98M in Q1 2022. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Yousif Capital Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Yousif Capital Management sold 11,272 Amedisys shares in Q3 2025, an estimated $1.11M.
  • Yousif Capital Management first reported a position in Amedisys in Q4 2021 and held it in 15 quarters.
  • Yousif Capital Management's Amedisys position peaked at $2.98M in Q1 2022.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Yousif Capital Management's 13F filing for Q3 2025, filed 14 Oct 2025.